Dr. Mudaliar has focused his research in the clinical aspects of type 2 diabetes, especially focusing on novel agents for its prevention and treatment. He has been the Principal Investigator (PI) on over 20 projects at our center, including ACTOS NOW, a major study in the prevention of diabetes. Currently, he is the PI on several industry sponsored grants, evaluating newer medications for the treatment of type 2 diabetes.

He is also a Co-investigator in the NIH/NIDDK sponsored multicenter Diabetes Prevention Program Outcome Study, “DPPOS”. This study is a continuation of the earlier landmark diabetes study that showed the intensive lifestyle modification with diet/exercise or intervention with metformin significantly decreased the incidence of diabetes in patients with pre-diabetes.

Another NIH funded study on which I am a Co-Investigator is a study evaluating, “Metabolic Effects of Newer Antipsychotics in Older Patients.”

In addition to his research, Dr. Mudaliar is a Clinical Professor of Medicine, at the University of California, San Diego. He is active in the Ambulatory Care component of the University Med 401 Clerkship Program where students rotate through the VA hospital primary care/diabetes clinic.

During his inpatient months as Endocrine Consult Attending (2 months) and Medicine Ward Attending (1 month), he teaches students, residents and fellows. He is also involved annually in the OSCE (Objective Structured Clinical Examination) for second year medical students and gives regular lectures/presents cases in the didactic seminar component of Med 401 course on diabetes.

Dr. Mudaliar has also been a member of the UCSD Human Research Protections Program since 2002. He is a Board-certified Physician and Endocrinologist and works as a clinician within the VA Medical Center Primary Care and Diabetes Care Clinic, Lipid Clinic, General Medicine, Endocrine Consult Service, and the Inpatient Diabetes Consult Service.